Join your colleagues for a Live Educational Symposium entitled,
Innovation in Action: The Impact of Cell-Based Influenza Vaccines
Sponsored by CSL Seqirus.
Breakfast Will be Served
The objectives for this program will be to:
- Understand the burden of influenza in the United States (US) and the continued decline in influenza vaccination coverage, with a particular emphasis on the pediatric population
- Discuss and explore advancements in influenza vaccine technology
- Explore the potential benefits of cell-based influenza vaccines for both children and adults
- Focus on the insights provided by real-world evidence (RWE) regarding vaccine effectiveness and its impact on patient care
Saturday, April 25, 2026
6:45 AM - 8:00 AM ET
Omni Boston Hotel at the Seaport
Ensemble Ballroom C (Level 2)
450 Summer Street
Boston, MA 02210
Ravi Jhaveri MD, FIDSA, FPIDS, FAAP
Division Head
Pediatric Infectious Diseases
Virginia H. Rogers Professor in Infectious Diseases
Ann & Robert H. Lurie Children's Hospital of Chicago
Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Pre-registration is for planning purposes only.
Seating will be available on a first-come, first-served basis.
Please be advised that the food and beverage value for this program will be tracked and reported in accordance with applicable transparency laws, including, but not limited to, Open Payments (Sunshine Act).
This presentation may include information on vaccines, drugs, biologics or devices, or use of vaccines, drugs, biologics or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only.
CSL Seqirus is committed to the free exchange and advancement of medical and scientific education. Inclusion of any presentation in this program, including presentation of off-label uses, does not imply an endorsement by CSL Seqirus of the uses, products, or techniques presented.